See the DrugPatentWatch profile for Biktarvy
What are the alternatives to Biktarvy?
When seeking alternatives to Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide), several factors come into play, including drug class, specific therapeutic needs, and potential side effects. Biktarvy is a single-tablet regimen used to treat HIV-1 infection.
What other single-tablet HIV treatments are available?
Other single-tablet regimens offer different combinations of antiretroviral drugs. Examples include:
* Descovy (emtricitabine/tenofovir alafenamide) combined with other agents like elvitegravir/cobicistat (Stribild) or rilpivirine (Odefsey) [1].
* Triumeq (abacavir/dolutegravir/lamivudine) is another option, though abacavir requires genetic testing for HLA-B*5701 to assess hypersensitivity risk [2].
* Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a complete regimen in one pill [1].
* Dovato (dolutegravir/lamivudine) is a two-drug regimen that may be considered for certain individuals [3].
Why might someone switch from Biktarvy?
Reasons for switching from Biktarvy can include experiencing side effects, drug interactions, or changes in health status. For instance, some individuals might seek alternatives if they develop adverse reactions or if their healthcare provider determines a different regimen is more suitable. The choice of alternative often depends on individual patient factors and the specific goals of HIV therapy.
What are the different classes of HIV medications?
HIV medications, often used in combination, belong to several drug classes, each targeting different stages of the HIV life cycle:
* Integrase Strand Transfer Inhibitors (INSTIs): Biktarvy contains bictegravir, an INSTI. Other INSTIs include dolutegravir, raltegravir, and elvitegravir [4].
* Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Emtricitabine and tenofovir alafenamide in Biktarvy are NRTIs. Other NRTIs include abacavir, lamivudine, and tenofovir disoproxil fumarate [4].
* Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Examples include efavirenz, rilpivirine, and doravirine [4].
* Protease Inhibitors (PIs): Drugs like darunavir and atazanavir are PIs [4].
* Entry Inhibitors and Fusion Inhibitors: These drugs, such as enfuvirtide, prevent HIV from entering cells [4].
* CCR5 Antagonists: Maraviroc is an example of this class [4].
When does Biktarvy's patent expire?
Patent protection for medications like Biktarvy is crucial for drug manufacturers. The patent landscape for Biktarvy and its components is complex, involving multiple patents covering the drug itself, its formulations, and its uses. According to DrugPatentWatch.com, the patent status and expiry dates can vary significantly for different patents associated with Biktarvy [5]. Information on specific patent expiry dates and any associated litigation can be found by searching the DrugPatentWatch database [5].
---
Sources
[1] Gilead Sciences, Inc. Genvoya (elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide) prescribing information.
[2] ViiV Healthcare. Triumeq (abacavir, dolutegravir, lamivudine) prescribing information.
[3] ViiV Healthcare. Dovato (dolutegravir, lamivudine) prescribing information.
[4] U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV.
[5] DrugPatentWatch.com.